Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiviral Therapy in Infants With HBV Infection
NCT06503796Phase 4Not yet recruiting
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Aug 2024
- Primary completion
- Nov 2025
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamivudine, antiviral lozenge in hepatitis B (HBV), sponsored by The Fifth Medical Center of the PLA General Hospital. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
lamivudineantiviral lozenge
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT06503796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06503796.